Screening for Prostate Cancer—Beyond Total PSA, Utilization of Novel Biomarkers
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Screening for Prostate Cancer—Beyond Total PSA, Utilization of Novel Biomarkers
Authors
Keywords
Prostate cancer biomarkers, PSA, [−2]proPSA, Free PSA, PCA3, TMPRSS2:erg
Journal
Current Urology Reports
Volume 16, Issue 9, Pages -
Publisher
Springer Nature
Online
2015-07-13
DOI
10.1007/s11934-015-0537-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The PCA3 test for guiding repeat biopsy of prostate cancer and its cut-off score: a systematic review and meta-analysis
- (2014) Xin Gou et al. ASIAN JOURNAL OF ANDROLOGY
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Added Value of Percentage of Free to Total Prostate-specific Antigen, PCA3, and a Kallikrein Panel to the ERSPC Risk Calculator for Prostate Cancer in Prescreened Men
- (2014) Moniek M. Vedder et al. EUROPEAN UROLOGY
- Comparative Evaluation of Urinary PCA3 and TMPRSS2: ERG Scores and Serum PHI in Predicting Prostate Cancer Aggressiveness
- (2014) Lucile Tallon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer?
- (2014) John T. Wei et al. JOURNAL OF CLINICAL ONCOLOGY
- Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
- (2014) Fritz H Schröder et al. LANCET
- RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1
- (2014) John R Prensner et al. LANCET ONCOLOGY
- A Novel RNA In Situ Hybridization Assay for the Long Noncoding RNA SChLAP1 Predicts Poor Clinical Outcome After Radical Prostatectomy in Clinically Localized Prostate Cancer
- (2014) Rohit Mehra et al. NEOPLASIA
- Serum Isoform [−2]proPSA Derivatives Significantly Improve Prediction of Prostate Cancer at Initial Biopsy in a Total PSA Range of 2–10 ng/ml: A Multicentric European Study
- (2013) Massimo Lazzeri et al. EUROPEAN UROLOGY
- PCA3 and PCA3-Based Nomograms Improve Diagnostic Accuracy in Patients Undergoing First Prostate Biopsy
- (2013) Alain Ruffion et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex
- (2013) John R Prensner et al. NATURE GENETICS
- Correlation of UrineTMPRSS2:ERGandPCA3to ERG+ and Total Prostate Cancer Burden
- (2012) Allison Young et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- From prostate-specific antigen (PSA) to precursor PSA (proPSA) isoforms: a review of the emerging role of proPSAs in the detection and management of early prostate cancer
- (2012) Satoshi Hori et al. BJU INTERNATIONAL
- Initial Prostate Biopsy: Development and Internal Validation of a Biopsy-specific Nomogram Based on the Prostate Cancer Antigen 3 Assay
- (2012) Jens Hansen et al. EUROPEAN UROLOGY
- Urine PCA3 and TMPRSS2:ERG Using Cancer-specific Markers to Detect Cancer
- (2012) Scott A. Tomlins EUROPEAN UROLOGY
- Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer
- (2012) Gisele H.J.M. Leyten et al. EUROPEAN UROLOGY
- Longitudinal Changes of Benign Prostate-specific Antigen and [−2]Proprostate-specific Antigen in Seven Years in a Community-based Sample of Men
- (2012) Thomas Rhodes et al. UROLOGY
- Early detection of clinically significant prostate cancer at diagnosis: a prospective study using a novel panel ofTMPRSS2:ETSfusion gene markers
- (2012) Sam W. Chan et al. Cancer Medicine
- A Panel of Kallikrein Marker Predicts Prostate Cancer in a Large, Population-Based Cohort Followed for 15 Years without Screening
- (2011) A. J. Vickers et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Prostate Cancer Screening—The Evidence, the Recommendations, and the Clinical Implications
- (2011) Roger Chou et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range
- (2011) William J. Catalona et al. JOURNAL OF UROLOGY
- Benign Prostate Specific Antigen Distribution and Associations With Urological Outcomes in Community Dwelling Black and White Men
- (2011) Thomas Rhodes et al. JOURNAL OF UROLOGY
- Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA
- (2011) S. A. Tomlins et al. Science Translational Medicine
- Intact and Internally Cleaved Free Prostate-Specific Antigen in Patients With Prostate Cancer With Different Pathologic Stages and Grades
- (2011) Mari T. Peltola et al. UROLOGY
- A Prospective, Multicenter, National Cancer Institute Early Detection Research Network Study of [-2]proPSA: Improving Prostate Cancer Detection and Correlating with Cancer Aggressiveness
- (2010) L. J. Sokoll et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- A Four-Kallikrein Panel Predicts Prostate Cancer in Men with Recent Screening: Data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam
- (2010) A. J. Vickers et al. CLINICAL CANCER RESEARCH
- Mortality Results from a Randomized Prostate-Cancer Screening Trial
- (2009) Gerald L. Andriole et al. NEW ENGLAND JOURNAL OF MEDICINE
- Screening and Prostate-Cancer Mortality in a Randomized European Study
- (2009) Fritz H. Schröder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy
- (2008) Alexander Haese et al. EUROPEAN UROLOGY
- PCA3 Molecular Urine Assay Correlates With Prostate Cancer Tumor Volume: Implication in Selecting Candidates for Active Surveillance
- (2008) Hiroyuki Nakanishi et al. JOURNAL OF UROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now